MedTrace Logo

Eardream Data Collection in Switzerland Supported by ADDF

NCT05320471 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2022-10-06

No results posted yet for this study

Summary

data collection based on this study will allow us to collect and calibrate neurophysiological and cognitive data collected from in-ear EEG recordings of the initial baseline/reference population in Swiss healthy individuals that can be used as reference to data collected in other populations, for instance, to be compared with any other similar dataset in the future (e.g., Alzheimer patient cohorts).

Conditions

  • Healthy Aging

Interventions

OTHER

This is an observational study

This is an observational study

Sponsors & Collaborators

  • Alzheimer's Drug Discovery Foundation

    collaborator OTHER

  • Swiss Federal Institute of Technology

    lead OTHER

Principal Investigators

  • Rafael Polania, PhD · ETH Zurich

  • Caroline Lustenberger, PhD · ETH Zurich

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-20
Primary Completion
2023-06-01
Completion
2023-06-01

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05320471 on ClinicalTrials.gov